{"id":323594,"date":"2026-03-11T05:18:08","date_gmt":"2026-03-11T05:18:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/323594\/"},"modified":"2026-03-11T05:18:08","modified_gmt":"2026-03-11T05:18:08","slug":"gop-sen-johnson-investigating-fda-rare-disease-drug-rejections","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/323594\/","title":{"rendered":"GOP Sen. Johnson investigating FDA rare disease drug rejections"},"content":{"rendered":"

WASHINGTON \u2014\u00a0Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration\u2019s rejections of rare disease treatments<\/a>.<\/p>\n

The Wisconsin Republican is requesting denial letters, called complete response letters, that the FDA sent to makers of rare disease treatments for conditions including ataxia and Sanfilippo syndrome. He said he\u2019s heard that some of the issues in those letters are \u201cnitpicky things.\u201d\u00a0<\/p>\n

\u201cWe\u2019re going to find out exactly what issues the FDA listed for their \u2018nos\u2019,\u201d he said.<\/p>\n

STAT+ Exclusive Story<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\"STAT+\"\/<\/p>\n

\t\t\t\t\t
\n\t\t\t\t\t\t\"STAT+\"\/
\n\t\t\t\t\t<\/a><\/p>\n

\t\t\t\tThis article is exclusive to STAT+ subscribers
\n\t\t\t\tUnlock this article \u2014 plus daily intelligence on Capitol Hill and the life sciences industry \u2014 by subscribing to STAT+.<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\t\t\tIndividual plans<\/p>\n

\t\t\t\t\t\tGroup plans<\/p>\n

\t\t\t\tView All Plans<\/a><\/p>\n

\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n

\t\t\t\t\tSubscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"WASHINGTON \u2014\u00a0Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration\u2019s rejections of rare disease…\n","protected":false},"author":2,"featured_media":323595,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[5299,8310,525,134,524,111,139,69,1674,7254,3541,1676],"class_list":{"0":"post-323594","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-biotech","9":"tag-congress","10":"tag-fda","11":"tag-health","12":"tag-medication","13":"tag-new-zealand","14":"tag-newzealand","15":"tag-nz","16":"tag-pharmaceuticals","17":"tag-policy","18":"tag-rare-disease","19":"tag-stat"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/323594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=323594"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/323594\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/323595"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=323594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=323594"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=323594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}